Pages without language links
Jump to navigation
Jump to search
The following pages do not link to other language versions.
Showing below up to 50 results in range #51,121 to #51,170.
- High density lipoprotein epidemiology and demographics
- High density lipoprotein future or investigational therapies
- High density lipoprotein historical perspective
- High density lipoprotein landmark trials
- High density lipoprotein medical therapy
- High density lipoprotein natural history, complications and prognosis
- High density lipoprotein overview
- High density lipoprotein pathophysiology
- High density lipoprotein physiology
- High density lipoprotein prevention
- High density lipoprotein screening
- High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study
- High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial
- High endothelial venules
- High energy X-rays
- High energy phosphate
- High energy visible light
- High frequency limit
- High frequency ventilation
- High grade astrocytoma
- High intensity focused ultrasound
- High mobility group
- High osmolar gap metabolic acidosis differential diagnosis
- High output failure
- High protein diet
- High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry
- High red cell distribution width associated with adverse outcomes in patients with coronary artery disease
- High resolution manometry
- High rising terminal
- High risk pregnancy
- High temperature corrosion
- High test peroxide
- High triglyceride natural history, prognosis and complications
- High triglyceride pathophysiology
- High vocal center
- Higher Population Council-General Secretariat
- Higher Power
- Highest intercostal artery
- Highland Hospital
- Highland Hospital (Oakland, California)
- Highland Spring
- Highlands Hospital
- Highlands Regional Medical Center
- Highly conserved sequence
- Highly sensitive person
- Hijama
- Hilary Jones (doctor)
- Hilda Mahmoudi
- Hildebrand solubility parameter
- Hill's model